Intuitive Surgical Inc (ISRG) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$374.12 after a previous close of US$375.01. During the day the price has varied from a low of USD367.66 to a high of USD375.46. The latest price was USD373.12 (25 minute delay). Intuitive Surgical is listed on the NASDAQ. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
Best for beginner
Our top pick for
Dividend investing
Intuitive Surgical's shares were split on a 3:1 basis on 4 October 2021. So if you had owned 1 share the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Intuitive Surgical shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Intuitive Surgical shares which in turn could have impacted Intuitive Surgical's share price.
| Open | US$374.12 |
|---|---|
| High | US$375.46 |
| Low | US$367.66 |
| Close | US$373.12 |
| Previous close | US$375.01 |
| Change | US$-1.89 |
| Change % | -0.504% |
| Volume | 1,243,852 |
| 52-week range | US$254.85 - US$403.759 |
|---|---|
| 50-day moving average | US$387.286 |
| 200-day moving average | US$332.714 |
| Target price | US$414.8 |
| PE ratio | 74.0815 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | US$5.03 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $373.12
| 1 week (2024-04-19) | 1.85% |
|---|---|
| 1 month (2024-03-26) | -6.16% |
| 3 months (2024-01-26) | -0.44% |
| 6 months (2023-10-26) | 43.78% |
| 1 year (2023-04-25) | 26.49% |
|---|---|
| 2 years (2022-04-25) | 46.25% |
| 3 years (2021-04-26) | 29.27% |
| 5 years (2019-04-26) | 115.63% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Intuitive Surgical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Intuitive Surgical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Intuitive Surgical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Intuitive Surgical shares trade at around 74x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Intuitive Surgical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.1258. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Intuitive Surgical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Intuitive Surgical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.2 billion (£1.7 billion).
The EBITDA is a measure of a Intuitive Surgical's overall financial performance and is widely used to measure stock profitability.
Over the last 12 months, Intuitive Surgical's shares have ranged in value from as little as US$254.85 up to US$403.759. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intuitive Surgical's is 1.385. This would suggest that Intuitive Surgical's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
| Revenue TTM | US$7.1 billion |
|---|---|
| Operating margin TTM | 23.35% |
| Gross profit TTM | US$4.2 billion |
| Return on assets TTM | 7.77% |
| Return on equity TTM | 14.83% |
| Profit margin | 25.24% |
| Book value | 37.773 |
| Market capitalisation | US$132.1 billion |
TTM: trailing 12 months
We're not expecting Intuitive Surgical to pay a dividend over the next 12 months.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Intuitive Surgical.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 31.63
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Intuitive Surgical's overall score of 31.63 (as at 12/31/2018) is nothing to write home about – landing it in it in the 60th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Intuitive Surgical is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.47/100
Intuitive Surgical's environmental score of 4.47 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Intuitive Surgical is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 13.18/100
Intuitive Surgical's social score of 13.18 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Intuitive Surgical is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 10.47/100
Intuitive Surgical's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Intuitive Surgical is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Intuitive Surgical scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Intuitive Surgical has, for the most part, managed to keep its nose clean.
Intuitive Surgical Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 31.63 |
|---|---|
| Total ESG percentile | 59.52 |
| Environmental score | 4.47 |
| Environmental score percentile | 3 |
| Social score | 13.18 |
| Social score percentile | 3 |
| Governance score | 10.47 |
| Governance score percentile | 3 |
| Level of controversy | 2 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Everything we know about the Sun Silver IPO, plus information on how to buy in.
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.